Why traditional diets don't work
95% of people regain weight after diets. The problem isn't willpower — it's biology.
Yo-yo effect
95% of people regain weight after dieting within 1-2 years. The body adapts to restrictions and slows metabolism.
Hormonal barrier
Hunger hormones rise with calorie restriction. You feel constant hunger, and willpower doesn't help.
Metabolic slowdown
During strict diets, the body enters "economy mode" — burning fewer calories. Weight loss stops even with minimal food intake.
Everyone who has tried to lose weight through diets knows this feeling: the first weeks weight drops, then everything stalls. You feel constant hunger, irritability, loss of energy. And after a few months the kilograms return — often with a surplus.
It's not your fault. Harvard University research confirms: when you sharply restrict calories, the hunger hormone ghrelin rises by 20-30%, while the satiety hormone leptin drops. Your brain receives a signal: "Eat more, we're in danger." That's why no diet produces lasting results for most people.
The modern approach to weight loss works differently. Instead of fighting biology, next-generation GLP-1 products work with your body: they naturally reduce appetite, help you feel full faster, and accelerate fat metabolism. This is weight loss without starvation, breakdowns, and the yo-yo effect.
Innovative products — a revolution in weight loss
A new generation of weight control products approved by FDA and EMA. They naturally reduce appetite and accelerate metabolism. Unlike diets, the effect is based on science, not willpower. Mounjaro (tirzepatide) — a dual GLP-1 and GIP agonist that showed the highest efficacy in the SURMOUNT-1 trial.
Mounjaro: up to -22% weight in 72 weeks
Comparison of leading weight loss products based on SURMOUNT-1 and STEP-1 clinical trial data
| Comparison | Mounjaro | Ozempic |
|---|---|---|
| Mechanism of action | GLP-1 + GIP (dual) | GLP-1 only |
| Average weight loss | -22.5% | -14.9%* |
| Clinical trial | SURMOUNT-1 (2,539 participants) | STEP-1 (1,961 participants) |
| Manufacturer | Eli Lilly | Novo Nordisk |
| Frequency | Once/week | Once/week |
* STEP-1: semaglutide 2.4 mg/week (weight loss dose, brand Wegovy). Ozempic — T2D brand, max 2 mg.
Why do we recommend Mounjaro specifically? The clinical trial results speak for themselves: in the SURMOUNT-1 study with 2,539 participants, tirzepatide demonstrated the highest efficacy among all weight control products. Participants on the maximum dose lost an average of 22.5% of their initial weight — significantly more than any other method.
For comparison: standard diets provide only 3-5% weight loss, and most other products 10-15%. Mounjaro is more effective due to its dual mechanism of action on GLP-1 and GIP receptors, making it the optimal choice for those who want to lose weight effectively and maintain results.
It's simple
DOZA Program — 3 steps to results
The entire process takes no more than 10 minutes from the first message to a ready plan. You don't waste time on queues, trips, or waiting. Everything happens online — at your own pace.
After starting the program, a DOZA specialist monitors your progress weekly: adjusts dosage, answers questions, provides nutrition and activity recommendations. You're never alone in the process — it's full support from start to results.
Our clients' results
Calculation
Weight loss prognosis with DOZA
How many kilograms you can lose and how long it takes
Calculation based on SURMOUNT-1 clinical trial data and average DOZA client results. Enter your current weight and goal — the calculator will show a realistic prognosis.
This is an approximate prognosis. Actual results depend on individual factors, chosen program, and adherence to specialist recommendations.
BMI Calculator — detailed calculation →Frequently asked
Answers to your questions
The first step is the most important
Free specialist consultation. We'll select the optimal program for your goals. Response in 5 minutes.
Message on TelegramResponse in 5 min · Free · No obligations
